JP Morgan Maintains Overweight on Anterix, Raises Price Target to $133

Benzinga · 2d ago
JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $50 to $133.